Funmi Adewale's Archive

Funmi Adewale graduated from Cornell University in January 2010 with a BS in Biological Sciences. She plans to pursue a graduate degree in the near future, and her long-term goal is to further the communication of scientific knowledge to non-scientists. Funmi joined The Myeloma Beacon team in November 2009. Raised in Pittsburgh, Pennsylvania, she currently lives near Charlotte, North Carolina. Her interests include music, writing, languages, and sleep.

Funmi Adewale has written 34 article(s) .

[ by and | Oct 6, 2010 4:01 pm | Comments Off ]
Caring For Someone With Multiple Myeloma – Part 3: The Toll Of Caregiving

This article is the third in a three-part series about caring for a loved one with multiple myeloma. The first article provides an introduction to caring for a cancer patient as well as resources for caregivers. The second article provides practical tips for caregivers, and the third article explains the tolls of being a caregiver.

When Nan Manzo’s husband Dom was diagnosed with multiple myeloma in 2008, their family doctor shared some advice about how to deal with the ups …

Tags: , , ,
Read the full story »
[ by and | Oct 1, 2010 1:12 pm | 2 Comments ]
Caring For Someone With Multiple Myeloma – Part 2: Practical Caregiving

This article is the second in a three-part series about caring for a loved one with multiple myeloma. The first article provides an introduction to caring for a cancer patient as well as resources for caregivers. The second article provides practical tips for caregivers, and the third article will explain the tolls of being a caregiver.

When Lori Puente’s husband Dave was diagnosed with multiple myeloma in 2008, she decided that she would need to take time off from work …

Tags: , , ,
Read the full story »
[ by and | Sep 29, 2010 3:20 pm | 4 Comments ]
Caring For Someone With Multiple Myeloma – Part 1: Introduction To Being A Caregiver

This article is the first in a three-part series about caring for a loved one with multiple myeloma. The first article provides an introduction to caring for a cancer patient as well as resources for caregivers. The second article will provide practical tips for caregivers, and the third article will explain the tolls of being a caregiver.

In October 2008, Dianna Allred’s husband, Mark, was diagnosed with multiple myeloma after suffering a severe spine fracture.

As Mark’s pain increased dramatically …

Tags: , , ,
Read the full story »
[ by | May 5, 2010 3:03 pm | One Comment ]
Zolinza-Velcade Combination May Be Effective In Relapsed/Refractory Myeloma

The results of a recent study suggest that Zolinza (vorinostat), in combination with Velcade (bortezomib), may be effective in patients with relapsed or refractory myeloma after prior treatment with Velcade. The study was published in the journal Clinical Lymphoma, Myeloma & Leukemia.

Velcade has become a standard first-line treatment option for multiple myeloma, but more and more patients are developing resistance to or relapsing after it. Zolinza is a new cancer drug that is already approved …

Tags: , , ,
Read the full story »
[ by | Apr 27, 2010 3:27 pm | Comments Off ]
Elafin May Be Good Indicator Of A Common Stem Cell Transplant Complication

The protein elafin may be a good indicator of graft-versus-host-disease (GVHD) in patients who underwent an allogeneic stem cell transplant. These findings were published recently in the journal Science Translational Medicine.

Stem cell transplantation is the preferred treatment plan for multiple myeloma patients under the age of 65. When patients cannot produce enough of their own healthy stem cells for an autologous transplant, they undergo an allogeneic transplant, in which they receive stem cells from a donor.

A common complication …

Tags: , , , ,
Read the full story »
[ by | Apr 16, 2010 4:42 pm | 3 Comments ]
Causes Of And Treatments For Multiple Myeloma Drug-Induced Nerve Damage

For multiple myeloma patients, treatment history and personal predisposition have been identified as two key factors that may predict if a patient treated with Velcade (bortezomib) or thalidomide (Thalomid) will develop tingling and pain from nerve damage in their limbs.

Thalidomide and Velcade are among the many myeloma treatments that are neurotoxic, which means that they cause damage to the body’s nervous system. As a result, multiple myeloma patients commonly experience tingling and pain from nerve damage in …

Tags: , , , , , ,
Read the full story »
[ by | Apr 1, 2010 12:04 pm | 2 Comments ]
Continuous, Low-Dose Cyclophosphamide And Prednisone Regimen Is Safe And Effective Salvage Treatment For Multiple Myeloma

In a study recently published in the journal Clinical Lymphoma, Myeloma & Leukemia, researchers determined that continuous treatment with cyclophosphamide (Cytoxan) and prednisone at low doses is effective and manageable in multiple myeloma patients who cannot tolerate conventional chemotherapy.

When myeloma patients are unresponsive to treatment or experience relapse, doctors implement their plan B, known generally as salvage therapy. Most salvage therapies consist of the same treatment drugs at an increased dosage or a combination treatment of the …

Tags: , , , ,
Read the full story »